Navigation Links
Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.

Researchers at the Saint Louis University Institute for Molecular Virology (IMV) have explained in molecular terms the infection of healthy cells with HIV virus. This discovery will open new doors //for the development of drugs to prevent HIV infections throughout the world.

It is said that the HIV infection is possible because of three vital proteins.

One is the Reverse Transcriptase. Secondly it is the Integrase protein. Thirdly it is the Protease protein.

These proteins are very important at the three stages of infection. Reverse Transcriptase converts the viral RNA into DNA.

Integrase brings the ends of the DNA together and facilitates in the integration of the viral DNA into the human DNA making it as a part of the cell. This prevents the immune system to attack the virus.

Protease process viral proteins and plays an important role in the making of infectious virus.

There are various drugs like AZT and other combination drugs to inhibit Reverse Transcriptase and Protease proteins but no single drug to act on Integrase.

Fluorescence Resonance Energy Transfer is a biophysical methodology which will interrupt the activity of the Integrase of holding the two ends of the viral DNA before integration.

Once this is interrupted then there is no chance of the integration of the HIV virus DNA with the human DNA and the net result HIV infection can be prevented.

Further research plans to use this technique to develop effective drugs against HIV infection. Also drugs aiming at the assembly and disassembly process will also be researched and developed.
,br>
'"/>




Page: 1

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Flaw Detected in Aggressive Breast Cancers
4. Molecular Computer Developed To perform Calculations From Within Human Body
5. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
6. Molecular Basis Of ALS Found
7. New Molecular Treatment Identified To Treat Blood Cell Cancers
8. Researchers Find Molecular "Brake" to Cell Death
9. Solitons Could Power Molecular Electronics, Artificial Muscles
10. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases
11. Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: